Furazabol
From Wikipedia, the free encyclopedia
| Image:Furazabol.png | |
|
Furazabol
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C20H30N2O2 |
| Mol. mass | 330.464 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Methyl Hydroxy Nandrolone, tradename furazabol, also spelled Methylhydroxynandrolone, or MHN for short, is a derivative of the anabolic steroid nandrolone. It differs from nandrolone by being methylated as an c-17alpha alkylate, which allows it to be taken orally.
 |
This chemistry article is a stub. You can help Wikipedia by expanding it. |
